RQ Biotechnology News and Activities

Acquisition, funding and merger involving RQ Biotechnology.

• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).

View the org chart displaying its 15 main executives

Most searched biographies at RQ Biotechnology

• Mike Westby, Chief Executive Officer
• Christian Schade, Executive Chairman of the Board
• Simon Watson, Head of Computational Biology

Popular executive movements at RQ Biotechnology

• Christian Schade has joined the company as Executive Chairman of the Board  (posted on June 24 2026).

Create your alert
to follow the executive moves at RQ Biotechnology.

RQ Biotechnology has 2,415 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).
• Boundless Bio will change its company name to Serapha Bio on Dec 31, 2026. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by RQ Biotechnology

Social media about RQ Biotechnology

• RQ Biotechnology on Wikipedia, Google News & Yahoo Finance
• RQ Biotechnology on LinkedIn, X (Twitter) & YouTube